Whole genome sequencing for breast cancer risk testing

29 July 2016

Authors: Dr Charlotte Warren-Gash, Dr Mark Kroese, Dr Hilary Burton, Professor Paul Pharoah

The PHG Foundation report Whole Genome Sequencing for breast cancer examines the impact of routine testing for inherited / heritable conditions using whole genome sequencing where these conditions are not part of the primary purpose of testing. The report uses the example of inherited breast cancer, and its findings are relevant across a range of cancers.